A Review of CONSORT Guidelines About Comparison Groups With a Focused Discussion on Implications for Rehabilitation Clinical Trials.


Journal

American journal of physical medicine & rehabilitation
ISSN: 1537-7385
Titre abrégé: Am J Phys Med Rehabil
Pays: United States
ID NLM: 8803677

Informations de publication

Date de publication:
03 2020
Historique:
entrez: 22 2 2020
pubmed: 23 2 2020
medline: 6 5 2020
Statut: ppublish

Résumé

We examined and appraised the Consolidated Standards of Reporting Trials (CONSORT) 2010 Statement and its extension from the perspective of the reporting of comparison groups (ie, interventions or control conditions against which an experimental intervention is compared) in clinical trials on rehabilitation topics. We downloaded the CONSORT 2010 Statement and all endorsed and unofficial extensions reported on the CONSORT and EQUATOR Web sites. We extracted all statements on the selection, design, delivery, or interpretation of data from comparison groups in clinical trials. We discussed preliminary findings during the Cochrane Rehabilitation Methodology Meeting in Kobe and then further by email before finalizing results. We identified 23 standards reported across the CONSORT 2010 Statement and 10 extensions. Overall, these standards address many, but not all, issues related to reporting of comparison groups in rehabilitation trials. We recommend that additional standards be created for the selection of types of comparisons, choices around reporting of "usual care," reporting of intended "mechanisms of control," and reporting a rationale for the hypothesized superiority of one intervention over another when superiority trial design are used. Rehabilitation research would benefit from development of a specific checklist and guidelines to help researchers make best use of existing extensions.

Identifiants

pubmed: 32079896
doi: 10.1097/PHM.0000000000001368
pii: 00002060-202003000-00003
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

191-197

Références

Levack WMM, Martin RA, Graham FP, et al.: Compared to what? An analysis of the management of control groups in Cochrane reviews in neurorehabilitation. Eur J Phys Rehabil Med 2019;55:353–63
Hart T, Fann JR, Novack TA: The dilemma of the control condition in experience-based cognitive and behavioural treatment research. Neuropsychol Rehabil 2008;18:1–21
Hart T: Challenges in the evaluation of neuropsychological rehabilitation effects. In: Wilson BA, Winegardner J, van Heugten CM, Ownsworth T (Eds), Neuropsychological Rehabilitation: The International Handbook. London: Francis & Taylor Group; 2017. p. 559–68
Roth EJ, Stenson KW, Powley S, et al.: Expiratory muscle training in spinal cord injury: a randomized controlled trial. Arch Phys Med Rehabil 2010;91:857–61
Lohse KR, Pathania A, Wegman R, et al.: On the reporting of experimental and control therapies in stroke rehabilitation trials: a systematic review. Arch Phys Med Rehabil 2018;99:1424–32
Brigham GS, Feaster DJ, Wakim PG, et al.: Choosing a control group in effectiveness trials of behavioral drug abuse treatments. J Subst Abuse Treat 2009;37:388–97
Begg C, Cho M, Eastwood S, et al.: Improving the quality of reporting of randomized controlled trials: the CONSORT statement. JAMA 1996;276:637–9
Schulz KF, Altman DG, Moher D: CONSORT 2010 statement: updated guidelines for reporting parallel group randomised trials. BMC Med 2010;8:18
Devereaux P, Manns BJ, Ghali WA, et al.: The reporting of methodological factors in randomized controlled trials and the association with a journal policy to promote adherence to the Consolidated Standards of Reporting Trials (CONSORT) checklist. Control Clin Trials 2002;23:380–8
Turner L, Shamseer L, Altman DG, et al.: Consolidated Standards of Reporting Trials (CONSORT) and the completeness of reporting of randomised controlled trials (RCTs) published in medical journals. Cochrane Database Syst Rev 2012
Levack WMM, Meyer T, Negrini S, et al.: Cochrane Rehabilitation Methodology Committee: an international survey of priorities for future work. Eur J Phys Rehabil Med 2017;53:814–7
Levack WM, Malmivaara A, Meyer T, et al.: Methodological problems in rehabilitation research. Report from a Cochrane Rehabilitation Methodology Meeting. Eur J Phys Rehabil Med 2019;55:319–21
Levack WMM, Rathore FA, Pollet J, et al.: One in 11 Cochrane reviews are on rehabilitation interventions, according to pragmatic inclusion criteria developed by Cochrane rehabilitation. Arch Phys Med Rehabil 2019;100:1492–8
Campbell MK, Piaggio G, Elbourne DR, et al.: Consort 2010 statement: extension to cluster randomised trials. BMJ 2012;345:e5661
Piaggio G, Elbourne DR, Altman DG, et al.: Group C: Reporting of noninferiority and equivalence randomized trials: an extension of the CONSORT statement. JAMA 2006;295:1152–60
Ioannidis JP, Evans SJ, Gøtzsche PC, et al.: Better reporting of harms in randomized trials: an extension of the CONSORT statement. Ann Intern Med 2004;141:781–8
Juszczak E, Altman DG, Hopewell S, et al.: Reporting of multi-arm parallel-group randomized trials: extension of the CONSORT 2010 Statement. JAMA 2019;321:1610–20
Vohra S, Shamseer L, Sampson M, et al.: CONSORT extension for reporting N-of-1 trials (CENT) 2015 Statement. BMJ 2015;350:h1738
Dwan K, Li T, Altman DG, et al.: CONSORT 2010 Statement: extension to randomised crossover trials. BMJ 2019;366:l4378
Pandis N, Chung B, Scherer RW, et al.: CONSORT 2010 statement: extension checklist for reporting within person randomised trials. BMJ 2017;357:j2835
Eldridge SM, Chan CL, Campbell MJ, et al.: CONSORT 2010 Statement: extension to randomised pilot and feasibility trials. BMJ 2016;355:i5239
Thabane L, Hopewell S, Lancaster GA, et al.: Methods and processes for development of a CONSORT extension for reporting pilot randomized controlled trials. Pilot Feasibility Stud 2016;2:25
Calvert M, Blazeby J, Altman DG, et al.: Reporting of patient-reported outcomes in randomized trials: the CONSORT PRO extension. JAMA 2013;309:814–22
Gewandter JS, Eisenach JC, Gross RA, et al.: Checklist for the preparation and review of pain clinical trial publications: a pain-specific supplement to CONSORT. Pain Rep 2019;4:e621
Davidson KW, Goldstein M, Kaplan RM, et al.: Evidence-based behavioral medicine: what is it and how do we achieve it? Ann Behav Med 2003;26:161–71
Nelson DL, Mathiowetz V: Randomized controlled trials to investigate occupational therapy research questions. Am J Occup Ther 2004;58:24–34
Gagnier JJ, Boon H, Rochon P, et al.: Recommendations for reporting randomized controlled trials of herbal interventions: explanation and elaboration. J Clin Epidemiol 2006;59:1134–49
Gagnier J, Boon H, Rochon P, et al.: Reporting random controlled trials of herbal medicines. Explore (NY) 2006;2:143–9
Cheng CW, Wu TX, Shang HC, et al.: CONSORT extension for Chinese herbal medicine formulas 2017: recommendations, explanation, and elaboration. Ann Intern Med 2017;167:112–21
Pandis N, Fleming PS, Hopewell S, et al.: The CONSORT Statement: application within and adaptations for orthodontic trials. Am J Orthod Dentofacial Orthop 2015;147:663–79
Dean ME, Coulter MK, Fisher P, et al.: Reporting data on homeopathic treatments (RedHot): a supplement to CONSORT. J Altern Complement Med 2007;13:19–23
Hopewell S, Clarke M, Moher D, et al.: CONSORT for reporting randomized controlled trials in journal and conference abstracts: explanation and elaboration. PLoS Med 2008;5:e20
Grant S, Mayo-Wilson E, Montgomery P, et al.: CONSORT-SPI 2018 Explanation and Elaboration: guidance for reporting social and psychological intervention trials. Trials 2018;19:406
Grant SP, Mayo-Wilson E, Melendez-Torres G, et al.: Reporting quality of social and psychological intervention trials: a systematic review of reporting guidelines and trial publications. PloS One 2013;8:e65442
Mayo-Wilson E, Grant S, Hopewell S, et al.: Developing a reporting guideline for social and psychological intervention trials. Trials 2013;14:242
Montgomery P, Grant S, Mayo-Wilson E, et al.: Reporting randomised trials of social and psychological interventions: the CONSORT-SPI 2018 extension. Trials 2018;19:407
Moher D, Hopewell S, Schulz KF, et al.: CONSORT 2010 explanation and elaboration: updated guidelines for reporting parallel group randomised trials. BMJ 2010;340:c322
Zwarenstein M, Treweek S, Gagnier JJ, et al.: Improving the reporting of pragmatic trials: an extension of the CONSORT statement. BMJ 2008;337:a2390
Boutron I, Altman DG, Moher D, et al.: CONSORT statement for randomized trials of nonpharmacologic treatments: a 2017 update and a CONSORT extension for nonpharmacologic trial abstracts. Ann Intern Med 2017;167:40–7
MacPherson H, Altman DG, Hammerschlag R, et al.: Revised standards for reporting interventions in clinical trials of acupuncture (STRICTA): extending the CONSORT statement. PLoS Med 2010;7:e1000261
Hoffmann TC, Glasziou PP, Boutron I, et al.: Better reporting of interventions: template for intervention description and replication (TIDieR) checklist and guide. BMJ 2014;348:g1687
Welch VA, Norheim OF, Jull J, et al.: CONSORT-Equity 2017 extension and elaboration for better reporting of health equity in randomised trials. BMJ 2017;359:j5085
Craig P, Dieppe P, Macintyre S, et al.: Developing and evaluating complex interventions: the new Medical Research Council guidance. BMJ 2008;337:979–83
Paradis E, Sutkin G: Beyond a good story: from Hawthorne effect to reactivity in health professions education research. Med Educ 2017;51:31–9
Levitt SD, List JA: Was there really a Hawthorne effect at the Hawthorne plant? An analysis of the original illumination experiments. Am Econ J Appl Econ 2011;3:224–38
Bramel D, Friend R: Hawthorne, the myth of the docile worker, and class bias in psychology. Am Psychol 1981;36:867–78
Adair JG, Sharpe D, Huynh C-L: Hawthorne control procedures in educational experiments: a reconsideration of their use and effectiveness. Rev Educ Res 1989;59:215–28
McCambridge J, Witton J, Elbourne DR: Systematic review of the Hawthorne effect: new concepts are needed to study research participation effects. J Clin Epidemiol 2014;67:267–77
Di Blasi Z, Harkness E, Ernst E, et al.: Influence of context effects on health outcomes: a systematic review. Lancet 2001;357:757–62

Auteurs

William M M Levack (WMM)

From the Rehabilitation Teaching and Research Unit, Department of Medicine, University of Otago, Wellington, New Zealand (WMML); Department of Rehabilitation Medicine, Faculty of Medicine, University of Malaya, Kuala Lumpur, Malaysia (JPE); Department of Physical Medicine and Rehabilitation, Feinberg School of Medicine, Northwestern University, Chicago, Illinois (AWH); Department of Biomedical, Surgical and Dental Sciences, University of Milan "La Statale," Italy (SN); and IRCCS Istituto Ortopedico Galeazzi, Milan, Italy (SN).

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH